Sarcomeric deficits underlie MYBPC1-associated myopathy with myogenic tremor
Authors:
- Janis StavusisJanis Stavusis
- Humberto C. JocaHumberto C. Joca
- Joel C. RobinettJoel C. Robinett
- Laurin HanftLaurin Hanft
- Jack VandermeulenJack Vandermeulen
- Runchen ZhaoRunchen Zhao
- Konstantinos KonstantopoulosKonstantinos Konstantopoulos
- Kerry S. McDonaldKerry S. McDonald
- Christopher WardChristopher Ward
- Aikaterini Kontrogianni-KonstantopoulosAikaterini Kontrogianni-Konstantopoulos
Open Access
- 8 October 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (19)
Abstract
Myosin binding protein-C slow (sMyBP-C) comprises a subfamily of cytoskeletal proteins encoded by MYBPC1 that is expressed in skeletal muscles where it contributes to myosin thick filament stabilization and actomyosin cross-bridge regulation. Recently, our group described the causal association of dominant missense pathogenic variants in MYBPC1 with an early-onset myopathy characterized by generalized muscle weakness, hypotonia, dysmorphia, skeletal deformities, and myogenic tremor, occurring in the absence of neuropathy. To mechanistically interrogate the etiologies of this MYBPC1 -associated myopathy in vivo, we generated a knock-in mouse model carrying the E248K pathogenic variant. Using a battery of phenotypic, behavioral, and physiological measurements spanning neonatal to young adult life, we found that heterozygous E248K mice faithfully recapitulated the onset and progression of generalized myopathy, tremor occurrence, and skeletal deformities seen in human carriers. Moreover, using a combination of biochemical, ultrastructural, and contractile assessments at the level of the tissue, cell, and myofilaments, we show that the loss-of-function phenotype observed in mutant muscles is primarily driven by disordered and misaligned sarcomeres containing fragmented and out-of-register internal membranes that result in reduced force production and tremor initiation. Collectively, our findings provide mechanistic insights underscoring the E248K-disease pathogenesis and offer a relevant preclinical model for therapeutic discovery.Keywords
Funding Information
- National Institutes of Health (T32 AR007592)
- National Institutes of Health (R01AR076373)
- National Institutes of Health (R01AR071618)
- National Institutes of Health (R01AR071614)
- Muscular Dystrophy Association (313579)
- American Heart Association (19POST34450156)
- Fulbright Scholar Program (PS00266997)
This publication has 43 references indexed in Scilit:
- Aging, Neuromuscular Decline, and the Change in Physiological and Behavioral Complexity of Upper-Limb Movement DynamicsJournal of Aging Research, 2012
- Genetic deletion of trkB.T1 increases neuromuscular functionAmerican Journal of Physiology-Cell Physiology, 2012
- Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1Human Molecular Genetics, 2010
- Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signalingAmerican Journal of Physiology-Cell Physiology, 2009
- Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophyNeurobiology of Disease, 2007
- The parallel rod floor test: a measure of ataxia in miceNature Protocols, 2007
- Adaptations in Skeletal Muscle Disuse or Decreased-Use AtrophyAmerican Journal of Physical Medicine & Rehabilitation, 2002
- Ca2+ dependence of loaded shortening in rat skinned cardiac myocytes and skeletal muscle fibresThe Journal of Physiology, 2000
- Complete sequence of human fast‐type and slow‐type muscle myosin‐binding‐protein C (MyBP‐C)European Journal of Biochemistry, 1993
- Skeletal Muscle Tremor and the Influence of Adrenergic DrugsJournal of Asthma, 1990